Antibodies to DNA.
暂无分享,去创建一个
[1] F. Quismorio,et al. CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. , 2010, Arthritis and rheumatism.
[2] R. Kimberly,et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. , 1997, The Journal of clinical investigation.
[3] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[4] R M Smith,et al. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. , 1997, The Journal of clinical investigation.
[5] Bernhard Hemmer,et al. Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone , 1997, The Journal of experimental medicine.
[6] R. Cantor,et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. , 1997, The Journal of clinical investigation.
[7] A. Rosen,et al. Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in LE , 1997, Lupus.
[8] C. Burns,et al. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response. , 1996, Journal of immunology.
[9] J. Lefkowith,et al. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. , 1996, The Journal of clinical investigation.
[10] M. Hylkema,et al. Significance of anti‐nuclear and anti‐extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice , 1996, Clinical and experimental immunology.
[11] F. Dammacco,et al. Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti‐DNA‐reactive IgG , 1996, Clinical and experimental immunology.
[12] J. Thornton,et al. Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA. , 1996, Molecular immunology.
[13] F. Arnett,et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. , 1996, The Journal of clinical investigation.
[14] M. Abrahamowicz,et al. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. , 1996, Arthritis and rheumatism.
[15] D. Isenberg,et al. Human T cell responses to autoantibody variable region peptides , 1995, Lupus.
[16] C. Kallenberg,et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. , 1995, Arthritis and rheumatism.
[17] C. Mohan,et al. Lupus: key pathogenic mechanisms and contributing factors. , 1995, Clinical immunology and immunopathology.
[18] E. Sercarz,et al. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. , 1995, The Journal of clinical investigation.
[19] A. Kumar,et al. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] D. Isenberg,et al. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. , 1995, Kidney international.
[21] T. Winkler,et al. Preferential recognition of specific DNA motifs by anti‐double‐stranded DNA autoantibodies , 1995, European journal of immunology.
[22] P. Limburg,et al. Prevention of relapses in systemic lupus erythematosus , 1995, The Lancet.
[23] B. Croker,et al. Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype (anti-F(ab')2) system. , 1995, The Journal of rheumatology.
[24] P. Yuan,et al. Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy. , 1995, Artificial organs.
[25] B. Tsao,et al. Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells. , 1995, Journal of immunology.
[26] A. Theofilopoulos. The basis of autoimmunity: Part II. Genetic predisposition. , 1995, Immunology today.
[27] G. Denomme,et al. The role of the immunoglobulin heavy chain in human anti-DNA antibody binding specificity. , 1995, Arthritis and rheumatism.
[28] J. Harley,et al. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity , 1995, The Journal of experimental medicine.
[29] Y. Shoenfeld. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] P. Linsley,et al. Treatment of murine lupus with CTLA4Ig. , 1994, Science.
[31] R. Burlingame,et al. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. , 1994, The Journal of clinical investigation.
[32] B. Tsao,et al. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. , 1994, International immunology.
[33] W. Emlen,et al. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. , 1994, Journal of immunology.
[34] B. Stollar. Molecular analysis of anti‐DNA antibodies , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] M. Satoh,et al. Systemic lupus erythematosus. Antibodies to DNA, DNA-binding proteins, and histones. , 1994, Rheumatic diseases clinics of North America.
[36] J. Swindle,et al. Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. , 1993, Journal of immunology.
[37] Y. Mizushima,et al. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. , 1993, Journal of immunology.
[38] C. Mohan,et al. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus , 1993, The Journal of experimental medicine.
[39] D. Pisetsky,et al. The fine specificity of monoclonal anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. , 1993, Journal of autoimmunity.
[40] B. Tsao,et al. Ig-transgenic mice as models for studying the regulation and role of anti-DNA antibodies in murine lupus , 1992 .
[41] U. Moens,et al. Antibodies to Eukaryotic, including Autologous, Native DNA are Produced during BK Virus Infection, but not after Immunization with Non‐Infectious BK DNA , 1992, Scandinavian journal of immunology.
[42] J. Kalden,et al. Analysis of immunoglobulin variable region genes from human IgG anti‐DNA hybridomas , 1992, European journal of immunology.
[43] H. Nishimura,et al. Somatically mutated IgG anti‐DNA antibody clonally related to germ‐line encoded IgM anti‐DNA antibody , 1992, European journal of immunology.
[44] M. Petri,et al. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. , 1991, Arthritis and rheumatism.
[45] K. Yoshinaga,et al. Anti-DNA idiotypes deposited in renal glomeruli of patients with lupus nephritis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[46] M. Petri,et al. Comparison of different methods of classifying patients with systemic lupus erythematosus. , 1991, The Journal of rheumatology.
[47] Willem,et al. Somatic mutations in the variable regions of a human IgG anti-double- stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus , 1991, The Journal of experimental medicine.
[48] M. Radic,et al. Ig H and L chain contributions to autoimmune specificities. , 1991, Journal of immunology.
[49] A. Todd-Pokropek,et al. Comparison of DNA antibody idiotypes in human sera: an international collaborative study of 19 idiotypes from 11 different laboratories. , 1990, Journal of autoimmunity.
[50] P. Limburg,et al. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. , 1990, Arthritis and rheumatism.
[51] P. Lipsky,et al. In vitro autoantibody production by normal adult and cord blood B cells. , 1990, The Journal of clinical investigation.
[52] K. Kalunian,et al. Idiotypic characteristics of immunoglobulins associated with systemic lupus erythematosus. Studies of antibodies deposited in glomeruli of humans. , 1989, Arthritis and rheumatism.
[53] W. Seaman,et al. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. , 1987, Journal of immunology.
[54] R. Schwartz,et al. Origins of anti-DNA autoantibodies. , 1985, The Journal of clinical investigation.
[55] D. Alarcón-Segovia,et al. Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated T gamma cells. , 1983, Clinical and experimental immunology.
[56] A. Weinstein,et al. Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus. , 1983, The American journal of medicine.
[57] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[58] N. Abdou,et al. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. , 1981, The Journal of clinical investigation.
[59] D. Gladman,et al. Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. , 1979, The American journal of medicine.
[60] G. Friou,et al. Lupus Nephritis: Varying Complement-Fixing Properties of Immuvnoglobulin G Antibodies to Antigens of Cel Nuclei , 1968, Science.
[61] P. Schur,et al. Immunologic factors and clinical activity in systemic lupus erythematosus. , 1968, The New England journal of medicine.
[62] B. Stollar,et al. The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. , 1967, The Journal of clinical investigation.
[63] H G KUNKEL,et al. Complement Fixation with Cell Nuclei and DNA in Lupus Erythematosus , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[64] F. Celada,et al. A DNA-Reacting Factor in Serum of a Patient with Lupus Erythematosus Diffusus.∗ , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[65] E. Holborow,et al. A Serum Factor in Lupus Erythematosus with Affinity for Tissue Nuclei , 1957, British medical journal.
[66] A. Komatsuda,et al. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. , 1997, Kidney international.
[67] M. Zouali. The structure of human lupus anti-DNA antibodies. , 1997, Methods.
[68] M. Radic,et al. Genetic and structural evidence for antigen selection of anti-DNA antibodies. , 1994, Annual review of immunology.
[69] B. Diamond,et al. The role of somatic mutation in the pathogenic anti-DNA response. , 1992, Annual review of immunology.
[70] J. Berden,et al. Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. , 1990, Immunology today.
[71] J. Winfield,et al. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. , 1977, The Journal of clinical investigation.